View Press Releases
-
Veeva Introduces Falcon Router for Agentic Triage of All Reporting Channels
Sep 20, 2026
-
Hospitals May Be Sitting on Millions in Untapped Medication Cost Savings
Intelliguard today announced the launch of its new Interactive ROI Calculator, designed to help hospital and health system leaders quickly estimate the potential five-year financial impact of improving how medications are managed across their organizations.
Sep 20, 2026
-
Sygnature Discovery establishes DEL screening collaboration with X-Chem
Sep 20, 2026
-
RealTime Laboratories Launches 31-Marker Mycotoxin Extensive Panel, the Most Comprehensive Urinary Mycotoxin Test on the Market
The expanded panel pairs the industry’s largest-ever marker count with methodology upgrades designed to give practitioners and patients the most comprehensive view of mold exposure yet, supporting more informed clinical decisions.
Sep 21, 2026
-
PubHive Named Best AI-Driven Pharmacovigilance Platform 2026
PubHive combines Human-in-the-Loop AI-Assisted Review, connected safety workflows, and traceable evidence management for pharmacovigilance.
Sep 21, 2026
-
Aranscia Announces Molecular Laboratory Integration Initiative with Northside Hospital to Advance Precision Oncology
Sep 21, 2026
-
Revecore Launches Legal Appeals Service to Pursue the Complex Denials Hospitals Struggle to Overturn
Sep 21, 2026
-
Amplifyer Bio Publishes Liquid Biopsy Preclinical Data on Showing up to 100-Fold Increase in ctDNA Recovery
Data shows priming agents improved sensitivity for disease detection and mutational profiling while preserving key cfDNA features.
Sep 21, 2026
-
New Publication Associates SherpaPak® Cardiac Transport System with Lower Costs Across Heart Transplant Care
Published in the special Focus Issue on Innovations in Heart Transplantation in the Journal of Cardiac Failure, the GUARDIAN-Heart analysis across 18 U.S. transplant centers identifies $14,982 in net per-patient cost savings across multiple measured categories spanning post-transplant support, hospital care, organ preservation, and readmissions.
Sep 21, 2026
-
BOC Sciences Announces October 2026 Webinars on Vaccine Development and DNA-Encoded Chemistry
Sep 22, 2026
-
Eppendorf introduces the new SpinPro® 8 R high-speed centrifuge
First new floor-standing centrifuge developed since the integration of himac into the Eppendorf Group SpinPro 8 R combines high-speed performance with up to 6 L capacity and a selection of 35 rotors
Sep 23, 2026
-
Astoriom Acquires Additional UK Storage Business to Expand Capacity and Service Offerings
• Acquisition of Sampled’s UK facility strengthens Astoriom’s position as a trusted provider of secure, compliant and quality-led sample stability and biorepository storage solutions • Offers broader coverage, additional technical expertise and increased operational resilience to help safeguard critical samples
Sep 23, 2026
-
Neuland accelerates peptide manufacturing expansion to meet rising customer demand
Sep 15, 2026
-
Big Picture Bio founded to identify, design and optimise promising cancer combination therapies
- New company founded by Deep Science Ventures veterans closes £1.5M (~$2M USD) pre-seed round and secures £700K (~$950K USD) Innovate UK funding - Founding team and advisors bring expertise from Deep Science Ventures, AstraZeneca, Exscientia and PhoreMost - Initially focused on cancer and immune-mediated diseases, Big Picture Bio’s platform identifies optimal combinations of drugs and sequencing to minimise residual disease
Sep 16, 2026
-
Avenda Health Expands Private Practice Network with the Deployment of Unfold AI at Arizona Urology, Bringing AI Prostate Cancer Mapping to the Southwest
Leading Phoenix urology practice adopts advanced AI cancer mapping to personalize surgical planning, enhance patient visualization, and pave the way for outpatient treatments
Sep 16, 2026
-
ZeOmega Named a Leader in IDC MarketScape: U.S. Care Coordination Application 2026 Vendor Assessment
Sep 17, 2026
-
Complex-molecule specialist Shilpa CDMO launches at CPHI Milan
Sep 15, 2026
-
Reckitt Plans $600 Million U.S. Expansion Across R&D and Manufacturing
Reckitt plans to invest up to $600 million across New Jersey and North Carolina to strengthen U.S. R&D, innovation and OTC manufacturing. The investment will create a new science and innovation center and expand its largest U.S. OTC facility to support Mucinex, Move Free and future healthcare product demand.
Sep 16, 2026
-
Magnitude Biosciences secures £1.3m investment to scale pioneering in vivo drug discovery platform
Sep 14, 2026
-
Zymo Research Ranks Among Top Performers in International AI Antibody Design Challenge
Dear Bio-IT World Editorial Team, My name is Nora Flynn and I am reaching out from Zymo Research to share our latest press release announcing Zymo Research’s top-tier performance in the AIntibody Design Challenge, an international benchmark of AI-driven antibody discovery published recently in Nature Biotechnology. We believe this development will be of significant interest to your audience, particularly those working in computational biology, protein engineering, drug discovery, bioinformatics, and artificial intelligence. The press release highlights Zymo Research’s top-four ranking in the affinity maturation challenge, where generated antibody variants demonstrated up to 75-fold improved binding affinity. Additionally, the press release reaffirms the company's continued investment in AI-driven protein design. Overall, the blinded, prospective AIntibody benchmark demonstrates the capabilities of AI-guided protein engineering paired with experimental validation, which could be especially valuable for researchers and professionals developing AI-enabled biologics discovery platforms, evaluating protein design technologies, or applying machine learning to therapeutic antibody optimization. We invite you to review the attached press release as an advance preview ahead of its public release tomorrow, September 16, 2026, at 6:00 AM PT. We would be grateful if you would consider sharing this news with your readers once the announcement is made public. If you require any additional information, high-resolution images, or would like to arrange an interview with one of our experts, please do not hesitate to reach out. I look forward to the opportunity to collaborate with your team. Thank you for your time and consideration.
Sep 15, 2026


